Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Go back to Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
(NASDAQ: CVKD) Delayed: 2.89 -0.12 (3.99%)
Previous Close $3.01    52 Week High
Open $3.02    52 Week Low
Day High $3.19    P/E N/A 
Day Low $2.89    EPS
Volume 40,854